These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 26827948)

  • 1. Inhibitors for the Vitamin D Receptor-Coregulator Interaction.
    Teske KA; Yu O; Arnold LA
    Vitam Horm; 2016; 100():45-82. PubMed ID: 26827948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of the first irreversible small molecule inhibitors of the interaction between the vitamin D receptor and coactivators.
    Nandhikonda P; Lynt WZ; McCallum MM; Ara T; Baranowski AM; Yuan NY; Pearson D; Bikle DD; Guy RK; Arnold LA
    J Med Chem; 2012 May; 55(10):4640-51. PubMed ID: 22563729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Agonist-triggered modulation of the activated and silent state of the vitamin D(3) receptor by interaction with co-repressors and co-activators.
    Herdick M; Carlberg C
    J Mol Biol; 2000 Dec; 304(5):793-801. PubMed ID: 11124027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonist- and inverse agonist-driven interactions of the vitamin D receptor and the constitutive androstane receptor with corepressor protein.
    Lempiäinen H; Molnár F; Macias Gonzalez M; Peräkylä M; Carlberg C
    Mol Endocrinol; 2005 Sep; 19(9):2258-72. PubMed ID: 15905360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SRC2-3 binds to vitamin D receptor with high sensitivity and strong affinity.
    Egawa D; Itoh T; Kato A; Kataoka S; Anami Y; Yamamoto K
    Bioorg Med Chem; 2017 Jan; 25(2):568-574. PubMed ID: 27890450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anticancer activity of VDR-coregulator inhibitor PS121912.
    Sidhu PS; Teske K; Feleke B; Yuan NY; Guthrie ML; Fernstrum GB; Vyas ND; Han L; Preston J; Bogart JW; Silvaggi NR; Cook JM; Singh RK; Bikle DD; Arnold LA
    Cancer Chemother Pharmacol; 2014 Oct; 74(4):787-98. PubMed ID: 25107568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corepressor excess shifts the two-side chain vitamin D analog Gemini from an agonist to an inverse agonist of the vitamin D receptor.
    Gonzalez MM; Samenfeld P; Peräkylä M; Carlberg C
    Mol Endocrinol; 2003 Oct; 17(10):2028-38. PubMed ID: 12843209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new class of vitamin D analogues that induce structural rearrangement of the ligand-binding pocket of the receptor.
    Inaba Y; Yoshimoto N; Sakamaki Y; Nakabayashi M; Ikura T; Tamamura H; Ito N; Shimizu M; Yamamoto K
    J Med Chem; 2009 Mar; 52(5):1438-49. PubMed ID: 19193059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Culture serum-induced conversion from agonist to antagonist of a Vitamin D analog, TEI-9647.
    Yamaoka K; Kim MS; Takada I; Takeyama K; Kamimura T; Kato S
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):177-83. PubMed ID: 16835013
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A structural basis for the species-specific antagonism of 26,23-lactones on vitamin D signaling.
    Peräkylä M; Molnár F; Carlberg C
    Chem Biol; 2004 Aug; 11(8):1147-56. PubMed ID: 15324816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural Studies of Vitamin D Nuclear Receptor Ligand-Binding Properties.
    Belorusova AY; Rochel N
    Vitam Horm; 2016; 100():83-116. PubMed ID: 26827949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptors.
    Pathrose P; Barmina O; Chang CY; McDonnell DP; Shevde NK; Pike JW
    J Bone Miner Res; 2002 Dec; 17(12):2196-205. PubMed ID: 12469913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 22S-butyl-1alpha,24R-dihydroxyvitamin D3: recovery of vitamin D receptor agonistic activity.
    Inaba Y; Nakabayashi M; Itoh T; Yoshimoto N; Ikura T; Ito N; Shimizu M; Yamamoto K
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):146-50. PubMed ID: 20211257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin D3 derivatives with adamantane or lactone ring side chains are cell type-selective vitamin D receptor modulators.
    Inaba Y; Yamamoto K; Yoshimoto N; Matsunawa M; Uno S; Yamada S; Makishima M
    Mol Pharmacol; 2007 May; 71(5):1298-311. PubMed ID: 17325131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel VDR antagonists based on the GW0742 scaffold.
    Teske KA; Bogart JW; Arnold LA
    Bioorg Med Chem Lett; 2018 Feb; 28(3):351-354. PubMed ID: 29287957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crystal structures of the vitamin D nuclear receptor liganded with the vitamin D side chain analogues calcipotriol and seocalcitol, receptor agonists of clinical importance. Insights into a structural basis for the switching of calcipotriol to a receptor antagonist by further side chain modification.
    Tocchini-Valentini G; Rochel N; Wurtz JM; Moras D
    J Med Chem; 2004 Apr; 47(8):1956-61. PubMed ID: 15055995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential regulation of keratinocyte differentiation by 1,25(OH)2D3, VDR, and its coregulators.
    Bikle D; Teichert A; Hawker N; Xie Z; Oda Y
    J Steroid Biochem Mol Biol; 2007 Mar; 103(3-5):396-404. PubMed ID: 17229570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of helix 12 of the vitamin D(3) receptor for the partial agonism of carboxylic ester antagonists.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Steinmeyer A; Carlberg C
    J Mol Biol; 2002 Jan; 315(2):229-38. PubMed ID: 11779241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retinoid X receptor is a nonsilent major contributor to vitamin D receptor-mediated transcriptional activation.
    Bettoun DJ; Burris TP; Houck KA; Buck DW; Stayrook KR; Khalifa B; Lu J; Chin WW; Nagpal S
    Mol Endocrinol; 2003 Nov; 17(11):2320-8. PubMed ID: 12893883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.